Dare Bioscience Inc
DARE
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.01M
Close$
$0.17
76.7% downside
Current Fair Value
76.7% downsideOvervalued by 76.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.01 Million |
|---|---|
| Enterprise Value | $-589,555.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.2 |
| Beta | 1.06 |
| Outstanding Shares | 14,889,832 |
Return
| Return on Equity | 1961.64% |
|---|---|
| Return on Assets | -49.12% |
| Return on Invested Capital | -212.53% |
Valuation & Multiples
| P/E Ratio | -0.93 |
|---|---|
| PEG | 3.62 |
| Price to Sales | - |
| Price to Book Ratio | -0.74 |
| Enterprise Value to Revenue | -0.43 |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.73 |
| Debt to Equity | -1.82 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$1,667
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$2.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.06%▲ 0.25% |
|---|---|
| Total Invested | $1.87M▼ 1.96% |
| Investors Holding | 24▼ 3.00% |
ESG Score
No data